Miyamoto Yoshitaka, Noguchi Hirofumi, Yukawa Hiroshi, Oishi Koichi, Matsushita Kenji, Iwata Hisashi, Hayashi Shuji
Department of Advanced Medicine in Biotechnology and Robotics, Nagoya University Graduate School of Medicine, Higashi-ku, Nagoya, Japan; †Department of Oral Disease Research, National Center for Geriatrics and Gerontology, Aichi, Japan; ‡Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
§ Department of Gastroenterological Surgery, Transplant and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan.
Cell Med. 2012 May 8;3(1-3):89-95. doi: 10.3727/215517912X639405. eCollection 2012 Jan.
Induced pluripotent stem (iPS) cells have attracted attention as a promising cell source for medical treatment that could replace marrow stromal cells (MSCs) and adipose tissue-derived stem cells (ASCs). These pluripotent cells can be induced in vitro and in vivo to differentiate into various tissues and organs. The cells will be useful for regenerative medicine, cell therapy, and drug screening. Vitrification is used, as well as a rapid-freeze method, for colony-forming iPS cells. However, the method requires a high degree of technical skill. We herein report a more convenient method for freezing iPS cells in suspension. We examined the proliferation potency of cryopreserved mouse iPS cells using culture medium, 10% DMSO, 10% glycerol, 5% DMSO, 5% glycerol, 5% DMSO + 5% glycerol, cell-freezing medium-DMSO, cell-freezing medium-glycerol, Cell Banker 1, Cell Banker 1, Cell Banker 2, and Cell Banker 3 as cryopreservation solutions. Among them, Cell Banker 3 showed the highest efficacy in terms of the proliferation of mouse iPS cells. The mouse iPS cells cryopreserved in Cell Banker 3 at -80°C for 12 months maintained a high proliferation rate and an undifferentiated status. The formation of teratomas was also examined. In conclusion, Cell Banker 3 allows for freezing of iPS cells in suspension.
诱导多能干细胞(iPS细胞)作为一种有前景的细胞来源,有望替代骨髓基质细胞(MSC)和脂肪组织来源的干细胞(ASC)用于医学治疗,因而备受关注。这些多能细胞可在体外和体内被诱导分化为各种组织和器官。这些细胞将对再生医学、细胞治疗及药物筛选有用。玻璃化冷冻法以及快速冷冻法被用于形成集落的iPS细胞。然而,该方法需要高度的技术技巧。我们在此报告一种更简便的悬浮状态下冷冻iPS细胞的方法。我们使用培养基、10%二甲基亚砜(DMSO)、10%甘油、5% DMSO、5%甘油、5% DMSO + 5%甘油、无细胞冷冻培养基 - DMSO、无细胞冷冻培养基 - 甘油、细胞冻存液1、细胞冻存液1、细胞冻存液2和细胞冻存液3作为冷冻保存液,检测了冷冻保存的小鼠iPS细胞的增殖能力。其中,细胞冻存液3在小鼠iPS细胞增殖方面显示出最高的效果。在细胞冻存液3中于-80°C冷冻保存12个月的小鼠iPS细胞保持了高增殖率和未分化状态。还检测了畸胎瘤的形成。总之,细胞冻存液3允许在悬浮状态下冷冻iPS细胞。